The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care
Express Scripts, a leading pharmacy benefit management organization, will list Viatris labelled biosimilar insulin Glargine as a preferred insulin brand on its National Preferred Formulary (NPF)
By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
U.S. FDA to decide whether to authorize a booster dose in the coming days
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
Subscribe To Our Newsletter & Stay Updated
